Total plasma exosomes from PD patients in stage II and III were profiled by proteomics, and three proteins (clusterin, complement C1r, and apolipoprotein A1) were found to be downregulated in PD compared to control [94]. The gene discussed is CLU; the disease is Parkinson disease.